Jump to ContentJump to Main Navigation
Show Summary Details
More options …

The B.E. Journal of Economic Analysis & Policy

Editor-in-Chief: Jürges, Hendrik / Ludwig, Sandra

Ed. by Auriol, Emmanuelle / Brunner, Johann / Fleck, Robert / Mastrobuoni, Giovanni / Mendola, Mariapia / Requate, Till / de Vries, Frans / Zulehner, Christine

4 Issues per year

IMPACT FACTOR 2017: 0.306
5-year IMPACT FACTOR: 0.492

CiteScore 2017: 0.50

SCImago Journal Rank (SJR) 2017: 0.414
Source Normalized Impact per Paper (SNIP) 2017: 0.531

See all formats and pricing
More options …
Volume 9, Issue 1


Volume 6 (2006)

Volume 4 (2004)

Volume 2 (2002)

Volume 1 (2001)

The Effect of Price on Pharmaceutical R&D

Abdulkadir Civan / Michael T. Maloney
Published Online: 2009-04-09 | DOI: https://doi.org/10.2202/1935-1682.1977


This work extends prior research that finds drug development is driven by demand factors such as mortality rates of the diseases new drugs are aimed at. Here we find that the number of drugs in the development pipeline is strongly positively related to the price of existing drugs treating those diseases. This gives us a direct price elasticity measure from which we can draw some inference about the effect on new drug development that might occur if the pricing regime in the United States were to change.

Keywords: pharmaceutical R&D; drug prices

About the article

Published Online: 2009-04-09

Citation Information: The B.E. Journal of Economic Analysis & Policy, Volume 9, Issue 1, ISSN (Online) 1935-1682, DOI: https://doi.org/10.2202/1935-1682.1977.

Export Citation

©2011 Walter de Gruyter GmbH & Co. KG, Berlin/Boston.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Duncan S. Gilchrist
American Economic Journal: Applied Economics, 2016, Volume 8, Number 4, Page 189
Pierre Dubois, Olivier de Mouzon, Fiona Scott-Morton, and Paul Seabright
The RAND Journal of Economics, 2015, Volume 46, Number 4, Page 844
Gilad Sorek
Health Economics, 2014, Volume 23, Number 1, Page 108

Comments (0)

Please log in or register to comment.
Log in